PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 8,771 shares of the business's stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $45.16, for a total transaction of $396,098.36. Following the completion of the sale, the chief executive officer directly owned 54,566,095 shares of the company's stock, valued at $2,464,204,850.20. The trade was a 0.02% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total value of $14,274.51.
- On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total value of $476,226.67.
- On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total transaction of $206,164.14.
- On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The shares were sold at an average price of $43.49, for a total transaction of $1,046,238.93.
- On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The stock was sold at an average price of $42.69, for a total transaction of $984,943.68.
- On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The shares were sold at an average price of $42.56, for a total transaction of $858,562.88.
- On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The shares were sold at an average price of $42.94, for a total transaction of $1,021,242.02.
- On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The stock was sold at an average price of $42.39, for a total transaction of $1,024,015.23.
- On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The stock was sold at an average price of $43.90, for a total transaction of $2,600,811.60.
- On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The shares were sold at an average price of $43.92, for a total value of $4,010,159.52.
PACS Group Stock Performance
Shares of NYSE:PACS traded down $0.15 during trading on Monday, hitting $44.61. 759,862 shares of the company traded hands, compared to its average volume of 904,574. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The business's fifty day moving average is $44.74 and its 200-day moving average is $39.08. The stock has a market capitalization of $7.06 billion, a price-to-earnings ratio of 25.93, a PEG ratio of 1.40 and a beta of -0.13. PACS Group, Inc. has a one year low of $9.69 and a one year high of $49.49.
PACS Group (NYSE:PACS - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%.The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. As a group, equities analysts predict that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. Weiss Ratings cut shares of PACS Group from a "hold (c+)" rating to a "hold (c)" rating in a research report on Wednesday, August 5th. Oppenheimer boosted their price target on shares of PACS Group from $48.00 to $57.00 and gave the company an "outperform" rating in a report on Monday, August 10th. Wall Street Zen lowered shares of PACS Group from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 8th. JPMorgan Chase & Co. lifted their target price on shares of PACS Group from $47.00 to $58.00 and gave the company an "overweight" rating in a research note on Friday, September 4th. Finally, UBS Group boosted their target price on shares of PACS Group from $57.00 to $60.00 and gave the stock a "buy" rating in a research report on Thursday, August 6th. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, PACS Group has an average rating of "Moderate Buy" and an average price target of $58.80.
Get Our Latest Analysis on PACS
Institutional Trading of PACS Group
A number of institutional investors and hedge funds have recently modified their holdings of PACS. Financial Management Professionals Inc. boosted its holdings in shares of PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company's stock worth $28,000 after acquiring an additional 235 shares in the last quarter. Jacobsen Capital Management boosted its stake in shares of PACS Group by 1.6% in the 1st quarter. Jacobsen Capital Management now owns 18,128 shares of the company's stock valued at $582,000 after purchasing an additional 294 shares during the last quarter. Larson Financial Group LLC raised its position in shares of PACS Group by 127.0% during the 4th quarter. Larson Financial Group LLC now owns 1,094 shares of the company's stock valued at $42,000 after acquiring an additional 612 shares during the last quarter. Strategic Advocates LLC lifted its stake in PACS Group by 18.5% in the fourth quarter. Strategic Advocates LLC now owns 5,182 shares of the company's stock valued at $203,000 after buying an additional 808 shares during the period. Finally, Peterson Wealth Services raised its holdings in PACS Group by 1.6% in the first quarter. Peterson Wealth Services now owns 53,672 shares of the company's stock worth $1,724,000 after purchasing an additional 854 shares during the period.
About PACS Group
(
Get Free Report)
PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.
The company's broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.